Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report.

Iams W, Beckermann KE, Neff AT, Mayer IA, Abramson VG
Med Oncol. 2013 30 (2): 568

PMID: 23564368 · PMCID: PMC3774143 · DOI:10.1007/s12032-013-0568-x

MeSH Terms (13)

Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Carboplatin Chemotherapy, Adjuvant Docetaxel Female Humans Middle Aged Receptor, ErbB-2 Taxoids Thrombotic Microangiopathies Trastuzumab

Connections (2)

This publication is referenced by other Labnodes entities:

Links